On 8th March 2021, the FDA is hosting a virtual public meeting on Patient-Focused Drug Development for Vitiligo. They are interested in hearing from people living with vitiligo, and people supporting those with vitiligo, on the impact of the condition on daily life and also views on treatment approaches.
What does the FDA do?
The FDA is responsible for public health in the US and is the regulatory authority for a number of areas including drugs and biologics.
Does FDA regulation have a global impact?
The FDA has formal and informal relationships with their foreign counterparts. The FDA’s international programs have grown and its experts are often called on to direct, manage and coordinate the growing body of international work involving the World Health Organisation and International Conference of Drug Regulatory Authorities.
Why is it important to attend?
Wherever you are in the world this is a hugely important opportunity to:
- Share the health effects and daily impacts of vitiligo
- Share your treatment goals
- Share the decision factors you considered when seeking out or selecting a treatment
- Influence the future of vitiligo treatments
- Demonstrate the interest and need that our community has in new treatment development
What format will the meeting take?
The meeting will take the form of a panel discussion covering a variety of topics. Organisers are now accepting responses to questions that will be discussed, and you can contribute to these as part of the event registration process.
How can I attend?
OR directly via Eventbrite
